diabetes

Showing NaN - NaN of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Enrolling by invitation
  • Diabetes
  • +4 more
    • Phoenix, Arizona
    • +26 more
    Jan 19, 2023

    TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence

    Active, not recruiting
    • Diabetes
    • +4 more
    • Observational
    • San Francisco, California
    • +5 more
    Jan 20, 2023

    Osteomyelitis, Diabetes, Amputation Trial in United States (Rifampin, Riboflavin Placebo)

    Recruiting
    • Osteomyelitis
    • +2 more
    • Phoenix, Arizona
    • +29 more
    Jan 13, 2023

    Stroke Incidence and Risk Factors in a Tri-ethnic Region

    Completed
    • Diabetes
    • +4 more
      • Miami, Florida
        University of Miami
      Jan 10, 2023

      Diabetes, Obesity Trial in United States (PF-06882961, Placebo)

      Completed
      • Diabetes
      • Obesity
      • Phoenix, Arizona
      • +37 more
      Nov 8, 2022

      Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

      Completed
      • Diabetes
      • Diabetes Mellitus, Type 2
      • Tuscumbia, Alabama
      • +105 more
      Jul 11, 2022

      Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

      Completed
      • Diabetes
      • Diabetes Mellitus, Type 2
      • Lancaster, California
      • +104 more
      Jul 11, 2022

      Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

      Completed
      • Diabetes
      • Diabetes Mellitus, Type 2
      • Birmingham, Alabama
      • +107 more
      Jul 11, 2022

      Diabetes Trial in United States (Blood glucose meter, Eversense CGM System)

      Recruiting
      • Diabetes
      • Blood glucose meter
      • Eversense CGM System
      • Los Angeles, California
      • +15 more
      Jun 15, 2022

      C-myc Biomarker Study for Diabetic Foot Ulcers

      Recruiting
      • Diabetes
      • +3 more
        • San Francisco, California
        • +5 more
        Mar 9, 2022

        Diabetes Trial in Miami (Human Pancreatic Islet Transplantation)

        Recruiting
        • Diabetes
        • Human Pancreatic Islet Transplantation
        • Miami, Florida
        • +1 more
        Feb 23, 2022

        Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Insulin degludec
        • Insulin glargine
        • Anniston, Alabama
        • +228 more
        Jan 6, 2022

        Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Faster-acting insulin aspart
        • +3 more
        • Concord, California
        • +166 more
        Jan 6, 2022

        Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Birmingham, Alabama
        • +184 more
        Jul 1, 2021

        Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 1
        • La Jolla, California
        • +107 more
        Mar 10, 2021

        Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Tucson, Arizona
        • +102 more
        Jan 14, 2021

        Diabetes, Senior Syndrome, Frailty Trial in Miami, Sweetwater (Diet, Exercise, Diet and exercise)

        Terminated
        • Diabetes
        • +2 more
        • Diet
        • +2 more
        • Miami, Florida
        • +3 more
        Jan 4, 2021

        Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Birmingham, Alabama
        • +81 more
        Oct 26, 2020

        Overweight, Diabetes, PreDiabetes Trial in Worldwide (Gelesis200, Placebo)

        Unknown status
        • Overweight
        • +3 more
        • Gelesis200
        • Placebo
        • Birmingham, Alabama
        • +29 more
        Jul 20, 2020

        Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Birmingham, Alabama
        • +231 more
        Jun 16, 2020

        Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

        Completed
        • Diabetes
        • Birmingham, Alabama
        • +83 more
        Jun 22, 2020

        Diabetes, Diabetes, Type 2, Cholesterolemia Trial in United States (Bempedoic acid + Ezetimibe FDC Oral Tablet, Ezetimibe 10 mg

        Completed
        • Diabetes
        • +2 more
        • Bempedoic acid + Ezetimibe FDC Oral Tablet
        • +3 more
        • Lincoln, California
        • +3 more
        Apr 8, 2020

        Obesity, Metabolic Syndrome, Diabetes Trial in Miami (Recombinant methionyl human leptin)

        Completed
        • Obesity
        • +2 more
        • Recombinant methionyl human leptin
        • Miami, Florida
          University of Miami, Center on Pharmacogenomics
        Feb 11, 2020

        Obesity, Metabolic Syndrome, Diabetes Trial in Miami (Recombinant methionyl human leptin)

        Completed
        • Obesity
        • +2 more
        • Recombinant methionyl human leptin
        • Miami, Florida
          University of Miami Miller School of Medicine, Center on Pharmac
        Feb 11, 2020

        Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

        Completed
        • Diabetes
        • Diabetes Mellitus, Type 2
        • Anaheim, California
        • +118 more
        Jan 8, 2020